TOST just delivered its Q2 results and the Street responded with a near-unanimous target raise — the clearest post-earnings analyst reaction the stock has seen in recent memory.
Ten firms raised price targets on August 5 alone. The direction was universal: every action was an upward revision, with no ratings cut and no one moving to the sidelines. Wells Fargo lifted its Overweight target to $40 from $36. Evercore ISI moved to $40 from $35. Needham went furthest, raising its Buy target to $45 from $35 — a 29% lift in a single session. Citigroup and Barclays both moved to $39. The consensus mean target now stands at $37.77, roughly 12% above the August 4 close of $33.81. Analyst recommendation divergence ranks in the 97th percentile versus the broader universe — an unusually tight consensus for a stock of this size. The split between bulls and bears is real but thin: bulls point to expanding margins, a full-stack POS and payments platform with 171,000 restaurant locations, and genuine cross-sell optionality. Bears counter that the Rule of 40 metric trails sector peers, the customer base skews toward high-churn SMB restaurants, and valuation already prices in much of the good news at a P/E above 20x and EV/EBITDA near 17.8x.
The short side of the ledger has quietly told a consistent story for weeks. Short interest has been grinding lower since peaking near 9.8% of the free float in early July. It now rests at 7.8% — still meaningful, but a clear retreat. The week-on-week change is a modest 1% decline, but the one-month move represents a 6.6% reduction in shares short. Availability is a loose 398%, up 11% on the week, meaning the lending pool has plenty of capacity relative to current short demand. Cost to borrow at 0.52% is near the bottom of its 30-day range. There is no squeeze pressure here — the covering that drove the earlier unwind appears to have absorbed the most aggressive shorts, leaving a residual position that looks more structural than momentum-driven.
Options positioning has normalised since the pre-earnings call skew. The put/call ratio ticked up to 0.63 from the sub-0.58 levels seen into the print. It remains below its 20-day average of 0.66 and nearly a full standard deviation beneath that mean — still net call-leaning but no longer at the extreme reading that preceded earnings. The 52-week PCR range runs from 0.44 to 0.82, which puts the current level comfortably in the middle, suggesting options traders have exhaled rather than repositioned defensively. The short score has also eased — dropping from 56.7 on July 23 to 52.4 today — reflecting both the fall in short interest and the improving price momentum that makes the existing short position less comfortable to hold.
One institutional note worth flagging: BlackRock added 20.7 million shares in the quarter to June 30, pushing its stake to 8.3% of shares outstanding. JP Morgan Asset Management added 6.8 million shares in the same period. That scale of institutional buying into a period when short interest was near its peak suggests the institutional base was actively fading the bearish thesis ahead of the earnings catalyst. Insider activity has been routine — a series of small scheduled sells by executives including the CEO and CFO, all at low significance scores, consistent with plan-driven liquidation rather than a directional signal.
The next test is how the stock holds above $33 in the days following the earnings-driven target upgrades — whether the revised analyst consensus at $37.77 attracts fresh buyers or whether the recent 17% monthly run prompts profit-taking before the targets are revisited again.
See the live data behind this article on ORTEX.
Open TOST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
